Details for New Drug Application (NDA): 087122
✉ Email this page to a colleague
NDA 087122 describes METHDILAZINE HYDROCHLORIDE, which is a drug marketed by Alpharma Us Pharms and is included in one NDA. Additional details are available on the METHDILAZINE HYDROCHLORIDE profile page.
The generic ingredient in METHDILAZINE HYDROCHLORIDE is methdilazine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the methdilazine hydrochloride profile page.
The generic ingredient in METHDILAZINE HYDROCHLORIDE is methdilazine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the methdilazine hydrochloride profile page.
Summary for 087122
| Tradename: | METHDILAZINE HYDROCHLORIDE |
| Applicant: | Alpharma Us Pharms |
| Ingredient: | methdilazine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 4MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
